❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ Project groups Tumor Biology ❭ Alfonso Urbanucci ❭ Research projects ❭

Research projects

 

  • Bioinformatics analysis of single cell sequencing (in collaboration with the Kuijjer Laboratory at NCMM and the Laboratories of Dr Urbanucci and Matti Nykter at Tampere University)
  • single cell technologies (affiliated with the Laboratories of Dr Urbanucci and Matti Nykter at Tampere University)
  • Molecular characterization of prostate cancer
  • Molecular classifiers for prostate cancer patients
  • Radiosensitizers in cancer
  • c-MYC and AR regulation
  • ATAD2 in prostate cancer (to be performed in the Laboratory of Dr Urbanucci in Tampere, Finland)
  • Genomics of melanomagenesis (In collaboration with the Lab of Eivind Hovig )
 
Page visits: 2163
Scroll to top

Home Eivind Hovig's group Genomic Regulation for Precision Cancer Medicine Lab [Urbanucci]

  • Group members
  • Former group members
  • Research projects
  • Prostate cancer research
  • Collaborators
  • Tweets
  • Publications
  • Selected publications
  • News
  • Contact us

Recent publications

Severson TM, Zhu Y, Prekovic S, Schuurman K, Nguyen HM, Brown LG, Hakkola S, Kim Y, Kneppers J, Linder S, Stelloo S, Lieftink C, van der Heijden M, Nykter M, van der Noort V, Sanders J, Morris B, Jenster G, van Leenders GJ, Pomerantz M, Freedman ML, Beijersbergen RL, Urbanucci A, Wessels L, Corey E et al. (2023)
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients
medRxiv
DOI 10.1101/2023.02.24.23286403, PubMed 36865297

Attard G, Parry M, Grist E, Mendes L, Dutey-Magni P, Sachdeva A, Brawley C, Murphy L, Proudfoot J, Lall S, Liu Y, Friedrich S, Ismail M, Hoyle A, Ali A, Haran A, Wingate A, Zakka L, Wetterskog D, Amos C, Atako N, Wang V, Rush H, Jones R, Leung H et al. (2023)
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial
Res Sq
DOI 10.21203/rs.3.rs-2488586/v1, PubMed 36798177

Cao S, Wang JR, Ji S, Yang P, Dai Y, Guo S, Montierth MD, Shen JP, Zhao X, Chen J, Lee JJ, Guerrero PA, Spetsieris N, Engedal N, Taavitsainen S, Yu K, Livingstone J, Bhandari V, Hubert SM, Daw NC, Futreal PA, Efstathiou E, Lim B, Viale A, Zhang J et al. (2022)
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
Nat Biotechnol, 40 (11), 1624-1633
DOI 10.1038/s41587-022-01342-x, PubMed 35697807

More publications

Get in touch

If you want to send us something, or just a postcard:

 

Alfonso Urbanucci, PhD

Department of Tumor Biology,

Institute for Cancer Research,

Oslo University Hospital,

PO Box 4950 Nydalen, 0424 Oslo Norway

 

Email: alfonso.urbanucci@rr-research.no

 

Visiting address:

The Norwegian Radium Hospital

Ullernchaussen 70, K-Bygget

4th Floor, Dept of Tumor Biology

Oslo, Norway

 

Shipping address:

OUS- Radium Hospital
Ullernchausseen 70
Department of Tumor Biology
K04071/Karen-Marie Heintz
0379 Oslo
Norway

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Email: trond.olav.berg@rr-research.no

Cookie policy

Accessibility statement (in Norwegian)